Skip to main content

Main navigation (without target group)

About Sobi
Our Patients
Countries and Products
Investigator Sponsored Studies
News
Careers
Contact Us

Breadcrumb

Home
News archive

Sobi successfully completes acquisition of Dova Pharmaceuticals

Please read more on sobi.com.

Footer Menu

Cookies
Terms of use

This site contains medical information that is intended for residents of the United States and Canada only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy

TEGSEDI® and AKCEA CONNECT® are registered trademarks of Akcea Therapeutics, Inc. Discovered and developed by Ionis Pharmaceuticals and distributed by Sobi, Inc.

TEGSEDI® and AKCEA CONNECT® are registered trademarks of Akcea Therapeutics, Inc. Discovered and developed by Ionis Pharmaceuticals and distributed by Sobi Canada, Inc.

Please do not modify code below!

Sobi United States
+1 781-786-7370
77 4th Avenue, 3rd Floor
Waltham, MA 02451, USA

Sobi Canada
+1 289-291-3852
1155 North Service Rd. West, Unit #11,
Oakville, Ontario, Canada L6M 3E3

This site contains medical information that is intended for residents of the United States and Canada only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy